Literature DB >> 18514243

Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt.

Doa'a A Saleh1, Fatma Shebl, Mohamed Abdel-Hamid, Shaker Narooz, Nabiel Mikhail, Manal El-Batanony, Sherif El-Kafrawy, Mai El-Daly, Soraya Sharaf, Mohamed Hashem, Samer El-Kamary, Laurence S Magder, Sonia K Stoszek, G Thomas Strickland.   

Abstract

A prospective cohort study of the incidence and risk factors for hepatitis C virus (HCV) infection was performed in 2171 pregnant women in three rural Egyptian villages who were HCV antibody (anti-HCV) and RNA (HCV-RNA) negative at baseline. During an average of 2.2 years follow up, 25 incident cases were observed, giving an estimated HCV incidence of 5.2/1000 person-years (PY). The infection rate correlated with community anti-HCV prevalence in pregnant women, while the perinatal incidence rate of 11.2/1000 PY was almost five times that of the non-perinatal rate (2.3/1000 PY). The data suggested iatrogenic perinatal risk factors were associated with infection in one village, while health education reduced infections in another. Among the 25 incident cases, eight were HCV-RNA negative when they were first found to be anti-HCV positive and one-third of the 15 viraemic cases with follow-up data available cleared their HCV-RNA after an average of 1.3 years. None of the 25 incident cases were jaundiced or had symptoms of hepatitis but elevated serum alanine aminotransferase levels confirmed hepatitis in nine. Our data suggest that asymptomatic HCV infections frequently occurred during the perinatal period but often cleared and that educating medical personnel on safe practices possibly reduced HCV transmission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514243      PMCID: PMC3793640          DOI: 10.1016/j.trstmh.2008.04.011

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  28 in total

1.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women.

Authors:  D Conte; M Fraquelli; D Prati; A Colucci; E Minola
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Educating health professionals: a hepatitis C educational program in a health maintenance organization.

Authors:  L R Fischer; K S Conboy; D H Tope; D K Shewmake
Journal:  Am J Manag Care       Date:  2000-09       Impact factor: 2.229

3.  Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study.

Authors:  M A Darwish; R Faris; N Darwish; A Shouman; M Gadallah; M S El-Sharkawy; R Edelman; K Grumbach; M R Rao; J D Clemens
Journal:  Am J Trop Med Hyg       Date:  2001 Mar-Apr       Impact factor: 2.345

4.  Changing patterns of acute viral hepatitis at a major urban referral center in Egypt.

Authors:  Soheir Zakaria; Rabab Fouad; Olfat Shaker; Sami Zaki; Ahmed Hashem; Samer S El-Kamary; Gamal Esmat; Serag Zakaria
Journal:  Clin Infect Dis       Date:  2007-01-17       Impact factor: 9.079

5.  Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.

Authors:  M A Nafeh; A Medhat; M Shehata; N N Mikhail; Y Swifee; M Abdel-Hamid; S Watts; A D Fix; G T Strickland; W Anwar; I Sallam
Journal:  Am J Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.345

6.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

7.  Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity.

Authors:  M Habib; M K Mohamed; F Abdel-Aziz; L S Magder; M Abdel-Hamid; F Gamil; S Madkour; N N Mikhail; W Anwar; G T Strickland; A D Fix; I Sallam
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

8.  Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence.

Authors:  F Abdel-Aziz; M Habib; M K Mohamed; M Abdel-Hamid; F Gamil; S Madkour; N N Mikhail; D Thomas; A D Fix; G T Strickland; W Anwar; I Sallam
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

9.  The association of health-care use and hepatitis C virus infection in a random sample of urban slum community residents in southern India.

Authors:  Melissa A Marx; K G Murugavel; Sudha Sivaram; P Balakrishnan; Mark Steinhoff; S Anand; David L Thomas; Suniti Solomon; David D Celentano
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

10.  Hepatitis c in a community in Upper Egypt: risk factors for infection.

Authors:  Ahmed Medhat; Magda Shehata; Laurence S Magder; Nabiel Mikhail; Laila Abdel-Baki; Mohamed Nafeh; Mohamed Abdel-Hamid; G Thomas Strickland; Alan D Fix
Journal:  Am J Trop Med Hyg       Date:  2002-05       Impact factor: 2.345

View more
  20 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants.

Authors:  Khaled AbdulQawi; Ahmed Youssef; Mohamed A Metwally; Ibrahim Ragih; Mohamed AbdulHamid; AbdulAziz Shaheen
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

3.  Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children.

Authors:  Doa'a A Saleh; Fatma M Shebl; Samer S El-Kamary; Laurence S Magder; Alif Allam; Mohamed Abdel-Hamid; Nabiel Mikhail; Mohamed Hashem; Soraya Sharaf; Sonia K Stoszek; G Thomas Strickland
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-02-12       Impact factor: 2.184

4.  Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.

Authors:  M F Derbala; A M Amer; M Almohanadi; A John; A Amin; A John; M Sharma; S R Alkaabi; N Z Al Dweik; F Pasic; R Yaqoob; M T Butt; F M Shebl
Journal:  J Viral Hepat       Date:  2010-11-25       Impact factor: 3.728

5.  Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt.

Authors:  F DeWolfe Miller; Laith J Abu-Raddad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

6.  Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages.

Authors:  Fatma M Shebl; Samer S El-Kamary; Doa'a A Saleh; Mohamed Abdel-Hamid; Nabiel Mikhail; Alif Allam; Hanaa El-Arabi; Ibrahim Elhenawy; Sherif El-Kafrawy; Mai El-Daly; Sahar Selim; Ayman Abd El-Wahab; Mohamed Mostafa; Soraya Sharaf; Mohamed Hashem; Scott Heyward; O Colin Stine; Laurence S Magder; Sonia Stoszek; G Thomas Strickland
Journal:  J Med Virol       Date:  2009-06       Impact factor: 2.327

7.  Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection.

Authors:  Samer S El-Kamary; Mona M Mohamed; Maissa El-Raziky; Michelle D Shardell; Olfat G Shaker; Wafaa A ElAkel; Gamal Esmat
Journal:  Liver Int       Date:  2013-03-20       Impact factor: 5.828

8.  Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation.

Authors:  F DeWolfe Miller; Mahmoud S Elzalabany; Sara Hassani; Diego F Cuadros
Journal:  World J Hepatol       Date:  2015-12-08

Review 9.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08

10.  Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virus.

Authors:  Samer S El-Kamary; Mohamed Hashem; Doaa A Saleh; Sayed F Abdelwahab; Maha Sobhy; Fatma M Shebl; Michelle D Shardell; G Thomas Strickland; Mohamed Tarek Shata
Journal:  J Pediatr       Date:  2012-08-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.